Bicycle Therapeutics (BCYC) Return on Capital Employed (QoQ) (2019 - 2026)

Bicycle Therapeutics (BCYC) Return on Capital Employed (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Bicycle Therapeutics 289.88 Mn 289.88 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -197.00
Dec 31, 2025 366.00
Sep 30, 2025 -286.00
Jun 30, 2025 -815.00
Mar 31, 2025 -571.00
Dec 31, 2024 -284.00
Sep 30, 2024 479.00
Jun 30, 2024 944.00
Mar 31, 2024 22.00
Dec 31, 2023 53.00
Sep 30, 2023 456.00
Jun 30, 2023 -404.00
Mar 31, 2023 -339.00
Dec 31, 2022 -607.00
Sep 30, 2022 -513.00
Jun 30, 2022 -343.00
Mar 31, 2022 133.00
Dec 31, 2021 987.00
Sep 30, 2021 134.00
Jun 30, 2021 255.00